Clinical Trials Browser

Phase 2/3 × INDUSTRY × Chalazion × Clear all

NCT01202747 2011-12-06

Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction

Phase 2/3 Completed

50 enrolled 4 charts

Dry Eye Syndromes, Chalazion